In recent years, an increasing number of scientific investigations have backed an alarming hypothesis: Alzheimer's disease may not be merely a condition of an aging brain, but the product of infection ...

More than a decade ago, a variant of the gene that encodes clusterin was identified as the third strongest genetic risk factor for late-onset Alzheimer's disease. It was recently reported that ...

"What we do know is that it’s possible to at least delay the onset of the symptoms of Alzheimer’s disease and give people more years of healthy life." The hope is that if late-onset Alzheimer ...

The Mediterranean-DASH Intervention for Neurodegenerative Delay, or MIND, diet was tied to a 9% to 25% lower risk for ...

The study does not address whether the treatment would benefit those with the more common late-onset Alzheimer’s disease, which typically affects people over 65 and involves different genetic ...

“If late-onset Alzheimer’s prevention trials have similar results to the DIAN-TU trials, there soon could be Alzheimer’s preventions available for the general population,” Bateman said.

Late-life depression was associated with a 95% increased risk of developing dementia. The association was stronger in studies ...

MMSE scores were linked with amyloid-beta 1-42 in late-onset Alzheimer's, vascular dementia, frontotemporal dementia, and unspecified dementia. MMSE scores also were tied to t-tau in late-onset ...

A recent study tests a new drug, gantenerumab on people with a genetically inherited form of Alzheimer’s disease. For people with this condition, dementia is almost inevitable. Gantenerumab ...